Status:
COMPLETED
Highly Active Antiretroviral Therapy (HAART) Adherence Interventions
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study proposes a 4-armed factorial randomized clinical trial in Nairobi, Kenya to determine the effect of cognitive and behavioral interventions on HAART adherence.
Detailed Description
The study will be a prospective randomized clinical control trial among HIV-1 seropositive adult participants beginning HAART (highly active antiretroviral therapy) for the first time. Patients who ar...
Eligibility Criteria
Inclusion
- Individuals must qualify for HAART treatment by World Health Organization (WHO) criteria (Clinical Stage IV disease) and/or CD4 count of less than 200 and plan to start HAART therapy.
- Must be above 18 years of age
- Must be HAART treatment-naïve
- Must agree to home visits, and plan to live in Kenya for at least two years.
Exclusion
- Individuals who are mentally incompetent or are pregnant are excluded from the study.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00273780
Start Date
May 1 2006
End Date
September 1 2008
Last Update
August 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hope Center for Infectious Diseases
Nairobi, Kenya